Combined treatment with p53-activating drug APR-246 and a sorted by
relevance

Admin23.09.2021

Combined treatment with p53-activating drug APR-246 and a

4101
Admin26.07.2021

Combined treatment with p53-activating drug APR-246 and a

7401
Admin24.09.2021

Combined treatment with p53-activating drug APR-246 and a

5506
Admin18.09.2021

Combined treatment with p53-activating drug APR-246 and a

5501
Admin30.07.2021

PL and PL-NPs inhibit DNMT-1 expression by MDA-MB-231 TNBC

7000
Admin18.07.2021

Combined treatment with p53-activating drug APR-246 and a

8609
Admin01.10.2021

[Full text] A combination of p53-activating APR-246 and

9301
Admin20.09.2021

Combined treatment with p53-activating drug APR-246 and a

2202
Admin27.07.2021

[Full text] A combination of p53-activating APR-246 and

Admin12.08.2021

[Full text] A combination of p53-activating APR-246 and

2207
Admin05.08.2021

[Full text] A combination of p53-activating APR-246 and

Admin25.07.2021

Inhibition of IL-4-and CD40ligation-induced IgG1, IgG2a

8601
Admin07.08.2021

Combined treatment with p53-activating drug APR-246 and a

5602
Admin07.09.2021

Combined treatment with p53-activating drug APR-246 and a

Admin12.08.2021

A thiol‐bound drug reservoir enhances APR‐246‐induced

4801
Admin29.07.2021

In vivo effects of APR-246 in combination with cisplatin

4401
Admin18.07.2021

[Full text] A combination of p53-activating APR-246 and

8204
Admin10.10.2021

Combined treatment with p53-activating drug APR-246 and a

4508
Admin14.07.2021

Combined treatment with p53-activating drug APR-246 and a

2407
Admin24.09.2021

(PDF) APR-246 overcomes resistance to cisplatin and

69010
Admin21.07.2021

(PDF) A combination of p53-activating APR-246 and

9405